Shared at <a href="https://twitter.com/hashtag/AHA2024?src=hashtag_click" target="_blank">#AHA2024</a>, the DEEP Trial results demonstrate improved QOL in patients with persistent and long-standing persistent Afib who underwent hybrid ablation and LAAE with an AtriClip® device.
To see more of the data, visit: <a href="https://t.co/aaFk2S3T8B" target="_blank">https://t.co/aaFk2S3T8B</a>
<a href="https://twitter.com/American_Heart" target="_blank">@American_Heart</a>
<a href="https://twitter.com/hashtag/Afib?src=hashtag_click" target="_blank">#Afib</a> <a href="https://twitter.com/hashtag/LAAE?src=hashtag_click" target="_blank">#LAAE</a>